Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonora, E.
Right arrow Articles by Muggeo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonora, E.
Right arrow Articles by Muggeo, M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 47, Issue 10 1643-1649, Copyright © 1998 by American Diabetes Association

ARTICLES

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study

E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, RC Bonadonna and M Muggeo
Division of Endocrinology and Metabolic Diseases, University of Verona Medical School and Azienda Ospedaliera di Verona, Italy.

The prevalence of insulin resistance in the most common metabolic disorders is still an undefined issue. We assessed the prevalence rates of insulin resistance in subjects with impaired glucose tolerance (IGT), NIDDM, dyslipidemia, hyperuricemia, and hypertension as identified within the frame of the Bruneck Study. The study comprised an age- and sex-stratified random sample of the general population (n = 888; aged 40-79 years). Insulin resistance was estimated by homeostasis model assessment (HOMA(IR)), preliminarily validated against a euglycemic-hyperinsulinemic clamp in 85 subjects. The lower limit of the top quintile of HOMA(IR) distribution (i.e., 2.77) in nonobese subjects with no metabolic disorders (n = 225) was chosen as the threshold for insulin resistance. The prevalence of insulin resistance was 65.9% in IGT subjects, 83.9% in NIDDM subjects, 53.5% in hypercholesterolemia subjects, 84.2% in hypertriglyceridemia subjects, 88.1% in subjects with low HDL cholesterol, 62.8% in hyperuricemia subjects, and 58.0% in hypertension subjects. The prevalence of insulin resistance in subjects with the combination of glucose intolerance (IGT or NIDDM), dyslipidemia (hypercholesterolemia and/or hypertriglyceridemia and/or low HDL cholesterol), hyperuricemia, and hypertension (n = 21) was 95.2%. In isolated hypercholesterolemia, hypertension, or hyperuricemia, prevalence rates of insulin resistance were not higher than that in nonobese normal subjects. An appreciable number of subjects (n = 85, 9.6% of the whole population) was insulin resistant but free of IGT, NIDDM, dyslipidemia, hyperuricemia, and hypertension. These results from a population-based study documented that 1) in hypertriglyceridemia and a low HDL cholesterol state, insulin resistance is as common as in NIDDM, whereas it is less frequent in hypercholesterolemia, hyperuricemia, and hypertension; 2) the vast majority of subjects with multiple metabolic disorders are insulin resistant; 3) in isolated hypercholesterolemia, hyperuricemia, or hypertension, insulin resistance is not more frequent than can be expected by chance alone; and 4) in the general population, insulin resistance can be found even in the absence of any major metabolic disorders.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Paz-Filho, K. Esposito, B. Hurwitz, A. Sharma, C. Dong, V. Andreev, T. Delibasi, H. Erol, A. Ayala, M.-L. Wong, et al.
Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients
Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1401 - E1408.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Johansson, S. Gandini, A. Guerrieri-Gonzaga, S. Iodice, M. Ruscica, B. Bonanni, M. Gulisano, P. Magni, F. Formelli, and A. Decensi
Effect of Fenretinide and Low-Dose Tamoxifen on Insulin Sensitivity in Premenopausal Women at High Risk for Breast Cancer
Cancer Res., November 15, 2008; 68(22): 9512 - 9518.
[Abstract] [Full Text] [PDF]

Home page
 ptjournalHome page
L. Stehno-Bittel
Intricacies of Fat
Physical Therapy, November 1, 2008; 88(11): 1265 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Kosmala, T. M. O'Moore-Sullivan, R. Plaksej, J. Kuliczkowska-Plaksej, M. Przewlocka-Kosmala, and T. H. Marwick
Subclinical Impairment of Left Ventricular Function in Young Obese Women: Contributions of Polycystic Ovary Disease and Insulin Resistance
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3748 - 3754.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Galletti, L. D'Elia, G. Barba, A. Siani, F. P. Cappuccio, E. Farinaro, R. Iacone, O. Russo, D. De Palma, R. Ippolito, et al.
High-Circulating Leptin Levels Are Associated with Greater Risk of Hypertension in Men Independently of Body Mass and Insulin Resistance: Results of an Eight-Year Follow-Up Study
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3922 - 3926.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Mineo, V. Ambrogi, L. Frasca, M. E. Cufari, E. Pompeo, and T. C. Mineo
Effects of Lung Volume Reduction Surgery for Emphysema on Glycolipidic Hormones
Chest, July 1, 2008; 134(1): 30 - 37.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Jensterle, A. Janez, B. Mlinar, J. Marc, J. Prezelj, and M. Pfeifer
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
Eur. J. Endocrinol., June 1, 2008; 158(6): 793 - 801.
[Abstract] [Full Text] [PDF]

Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
J. R. Churilla and R. F. Zoeller Jr
Physical Activity: Physical Activity and the Metabolic Syndrome: A Review of the Evidence
American Journal of Lifestyle Medicine, April 1, 2008; 2(2): 118 - 125.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. R. Berggren, K. E. Boyle, W. H. Chapman, and J. A. Houmard
Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E726 - E732.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. A. Marini, E. Succurro, S. Frontoni, M. L. Hribal, F. Andreozzi, R. Lauro, F. Perticone, and G. Sesti
Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women
Diabetes Care, August 1, 2007; 30(8): 2145 - 2147.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Cournil, R. Defay, A. Lacroux, S. Barny, A. Fontbonne, and for the CALDIA Study Group
Paradoxical Relationships Between Anthropometric Variables and Phenotypic Expression of the Metabolic Syndrome in Nondiabetic Polynesians of New Caledonia
Diabetes Care, July 1, 2007; 30(7): 1909 - 1911.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Bulhoes and L. Araujo
Metabolic Syndrome in Hypertensive Patients: Correlation between anthropometric data and laboratory findings
Diabetes Care, June 1, 2007; 30(6): 1624 - 1626.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
F. Donatelli, A. Vavassori, S. Bonfanti, P. Parrella, L. Lorini, R. Fumagalli, and F. Carli
Epidural Anesthesia and Analgesia Decrease the Postoperative Incidence of Insulin Resistance in Preoperative Insulin-Resistant Subjects Only
Anesth. Analg., June 1, 2007; 104(6): 1587 - 1593.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Guffanti, A. Caumo, L. Galli, A. Bigoloni, A. Galli, G. Dagba, A. Danise, L. Luzi, A. Lazzarin, and A. Castagna
Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects
Eur. J. Endocrinol., April 1, 2007; 156(4): 503 - 509.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
N. R. Madamanchi and M. S. Runge
Mitochondrial Dysfunction in Atherosclerosis
Circ. Res., March 2, 2007; 100(4): 460 - 473.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
O. Gumieniak, T. S. Perlstein, J. S. Williams, P. N. Hopkins, N. J. Brown, B. A. Raby, and G. H. Williams
Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension
Hypertension, March 1, 2007; 49(3): 461 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J. B. Meigs, R. C. Bonadonna, and M. Muggeo
Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population: The Bruneck Study
Diabetes Care, February 1, 2007; 30(2): 318 - 324.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. H. St-Pierre, A. D. Karelis, L. Coderre, F. Malita, J. Fontaine, D. Mignault, M. Brochu, J.-P. Bastard, K. Cianflone, E. Doucet, et al.
Association of Acylated and Nonacylated Ghrelin with Insulin Sensitivity in Overweight and Obese Postmenopausal Women
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 264 - 269.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
T. S. Perlstein, O. Gumieniak, G. H. Williams, D. Sparrow, P. S. Vokonas, M. Gaziano, S. T. Weiss, and A. A. Litonjua
Uric Acid and the Development of Hypertension: The Normative Aging Study
Hypertension, December 1, 2006; 48(6): 1031 - 1036.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Anthony, L. J. Reed, J. T. Dunn, E. Bingham, D. Hopkins, P. K. Marsden, and S. A. Amiel
Attenuation of Insulin-Evoked Responses in Brain Networks Controlling Appetite and Reward in Insulin Resistance: The Cerebral Basis for Impaired Control of Food Intake in Metabolic Syndrome?
Diabetes, November 1, 2006; 55(11): 2986 - 2992.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. B. Meigs, P. W. F. Wilson, C. S. Fox, R. S. Vasan, D. M. Nathan, L. M. Sullivan, and R. B. D'Agostino
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2906 - 2912.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
X. L. Wang, L. Zhang, K. Youker, M.-X. Zhang, J. Wang, S. A. LeMaire, J. S. Coselli, and Y. H. Shen
Free Fatty Acids Inhibit Insulin Signaling-Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase.
Diabetes, August 1, 2006; 55(8): 2301 - 2310.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
F. Bacha, R. Saad, N. Gungor, and S. A. Arslanian
Are Obesity-Related Metabolic Risk Factors Modulated by the Degree of Insulin Resistance in Adolescents?
Diabetes Care, July 1, 2006; 29(7): 1599 - 1604.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. H. Shen, L. Zhang, Y. Gan, X. Wang, J. Wang, S. A. LeMaire, J. S. Coselli, and X. L. Wang
Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling: A CROSS-TALK BETWEEN STRESS SIGNALING AND INSULIN SIGNALING IN RESISTIN-TREATED HUMAN ENDOTHELIAL CELLS
J. Biol. Chem., March 24, 2006; 281(12): 7727 - 7736.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. E. Zanolin, F. Tosi, G. Zoppini, R. Castello, G. Spiazzi, R. Dorizzi, M. Muggeo, and P. Moghetti
Clustering of Cardiovascular Risk Factors Associated With the Insulin Resistance Syndrome: Assessment by principal component analysis in young hyperandrogenic women
Diabetes Care, February 1, 2006; 29(2): 372 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
W. Tang, J. S. Pankow, and D. K. Arnett
RE: "(MIS)USE OF FACTOR ANALYSIS IN THE STUDY OF INSULIN RESISTANCE SYNDROME"
Am. J. Epidemiol., November 1, 2005; 162(9): 921 - 922.
[Full Text] [PDF]

Home page
 HypertensionHome page
D. Grassi, S. Necozione, C. Lippi, G. Croce, L. Valeri, P. Pasqualetti, G. Desideri, J. B. Blumberg, and C. Ferri
Cocoa Reduces Blood Pressure and Insulin Resistance and Improves Endothelium-Dependent Vasodilation in Hypertensives
Hypertension, August 1, 2005; 46(2): 398 - 405.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Levantesi, A. Macchia, R. Marfisi, M. G. Franzosi, A. P. Maggioni, G. L. Nicolosi, C. Schweiger, L. Tavazzi, G. Tognoni, F. Valagussa, et al.
Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 277 - 283.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
A. J. G. Hanley, J. B. Meigs, K. Williams, S. M. Haffner, and R. B. D'Agostino Sr.
Re: "(Mis)use of Factor Analysis in the Study of Insulin Resistance Syndrome"
Am. J. Epidemiol., June 15, 2005; 161(12): 1182 - 1184.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
D. Grassi, C. Lippi, S. Necozione, G. Desideri, and C. Ferri
Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons
Am. J. Clinical Nutrition, March 1, 2005; 81(3): 611 - 614.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Z. Kasa-Vubu, C. C. Lee, A. Rosenthal, K. Singer, and J. B. Halter
Cardiovascular Fitness and Exercise as Determinants of Insulin Resistance in Postpubertal Adolescent Females
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 849 - 854.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. Reinehr, W. Kiess, T. Kapellen, and W. Andler
Insulin Sensitivity Among Obese Children and Adolescents, According to Degree of Weight Loss
Pediatrics, December 1, 2004; 114(6): 1569 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
T. J Wilkin and L. D Voss
Metabolic syndrome: maladaptation to a modern world
J R Soc Med, November 1, 2004; 97(11): 511 - 520.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Ilanne-Parikka, J. G. Eriksson, J. Lindstrom, H. Hamalainen, S. Keinanen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Mannelin, M. Rastas, V. Salminen, et al.
Prevalence of the Metabolic Syndrome and Its Components: Findings from a Finnish general population sample and the Diabetes Prevention Study cohort
Diabetes Care, September 1, 2004; 27(9): 2135 - 2140.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J. B. Meigs, R. C. Bonadonna, and M. Muggeo
Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals: The Bruneck Study
Diabetes, July 1, 2004; 53(7): 1782 - 1789.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. Weiss, J. Dziura, T. S. Burgert, W. V. Tamborlane, S. E. Taksali, C. W. Yeckel, K. Allen, M. Lopes, M. Savoye, J. Morrison, et al.
Obesity and the Metabolic Syndrome in Children and Adolescents
N. Engl. J. Med., June 3, 2004; 350(23): 2362 - 2374.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. D. Karelis, D. H. St-Pierre, F. Conus, R. Rabasa-Lhoret, and E. T. Poehlman
Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2569 - 2575.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Borch-Johnsen, and K. Pyorala
Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women
Arch Intern Med, May 24, 2004; 164(10): 1066 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C.-E. Tan, S. Ma, D. Wai, S.-K. Chew, and E.-S. Tai
Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians?
Diabetes Care, May 1, 2004; 27(5): 1182 - 1186.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
T Reinehr and W Andler
Changes in the atherogenic risk factor profile according to degree of weight loss
Arch. Dis. Child., May 1, 2004; 89(5): 419 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
O. D. Howes, A. Bhatnagar, F. P. Gaughran, S. A. Amiel, R. M. Murray, and L. S. Pilowsky
A Prospective Study of Impairment in Glucose Control Caused by Clozapine Without Changes in Insulin Resistance
Am J Psychiatry, February 1, 2004; 161(2): 361 - 363.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. J. Murphy, B. S. Metcalf, L. D. Voss, A. N. Jeffery, J. Kirkby, K. M. Mallam, and T. J. Wilkin
Girls at Five Are Intrinsically More Insulin Resistant Than Boys: The Programming Hypotheses Revisited--The EarlyBird Study (EarlyBird 6)
Pediatrics, January 1, 2004; 113(1): 82 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. F. Ascaso, S. Pardo, J. T. Real, R. I. Lorente, A. Priego, and R. Carmena
Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism
Diabetes Care, December 1, 2003; 26(12): 3320 - 3325.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
D. E Kelley
Sugars and starch in the nutritional management of diabetes mellitus
Am. J. Clinical Nutrition, October 1, 2003; 78(4): 858S - 864.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, R. C. Bonadonna, and M. Muggeo
Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome: Prospective data from the Bruneck Study
Diabetes Care, April 1, 2003; 26(4): 1251 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. E. Gray, C. J. Tanner, W. J. Pories, K. G. MacDonald, and J. A. Houmard
Effect of weight loss on muscle lipid content in morbidly obese subjects
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E726 - E732.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. V. Williams, A. Bertoldo, B. Mattioni, J. C. Price, C. Cobelli, and D. E. Kelley
Glucose Transport and Phosphorylation in Skeletal Muscle in Obesity: Insight from a Muscle-Specific Positron Emission Tomography Model
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1271 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
Y.-W. Park, S. Zhu, L. Palaniappan, S. Heshka, M. R. Carnethon, and S. B. Heymsfield
The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the US Population From the Third National Health and Nutrition Examination Survey, 1988-1994
Arch Intern Med, February 24, 2003; 163(4): 427 - 436.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. J. Wilkin, B. S. Metcalf, M. J. Murphy, J. Kirkby, A. N. Jeffery, and L. D. Voss
The Relative Contributions of Birth Weight, Weight Change, and Current Weight to Insulin Resistance in Contemporary 5-Year-Olds: The EarlyBird Study
Diabetes, December 1, 2002; 51(12): 3468 - 3472.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. A. Houmard, C. J. Tanner, C. Yu, P. G. Cunningham, W. J. Pories, K. G. MacDonald, and G. I. Shulman
Effect of Weight Loss on Insulin Sensitivity and Intramuscular Long-Chain Fatty Acyl-CoAs in Morbidly Obese Subjects
Diabetes, October 1, 2002; 51(10): 2959 - 2963.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Azziz
Polycystic Ovary Syndrome, Insulin Resistance, and Molecular Defects of Insulin Signaling
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4085 - 4087.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
U. Riserus, P. Arner, K. Brismar, and B. Vessby
Treatment With Dietary trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men With the Metabolic Syndrome
Diabetes Care, September 1, 2002; 25(9): 1516 - 1521.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Hoybye, A. Hilding, H. Jacobsson, and M. Thoren
Metabolic Profile and Body Composition in Adults with Prader-Willi Syndrome and Severe Obesity
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3590 - 3597.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Marques-Vidal, E. Mazoyer, V. Bongard, P. Gourdy, J.-B. Ruidavets, L. Drouet, and J. Ferrieres
Prevalence of Insulin Resistance Syndrome in Southwestern France and Its Relationship With Inflammatory and Hemostatic Markers
Diabetes Care, August 1, 2002; 25(8): 1371 - 1377.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
F. Sugiyama, G. A. Churchill, R. Li, L. J. M. Libby, T. Carver, K.-I. Yagami, S. W. M. John, and B. Paigen
QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice
Physiol Genomics, July 12, 2002; 10(1): 5 - 12.
[Abstract] [Full Text] [PDF]